Publication: Prescribing pattern of lipid-lowering medications before and after adoption of 2013 american college of cardiology and american heart association guidelines in Thailand: An interrupted time series analysis
Issued Date
2021-09-22
Resource Type
ISSN
26975718
01251562
01251562
Other identifier(s)
2-s2.0-85119904033
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Southeast Asian Journal of Tropical Medicine and Public Health. Vol.52, No.5 (2021), 717-731
Suggested Citation
Suphannika Pornwattanakavee, Sanita Hirunrassamee, Aporanee Chaiyakum, Sauwakon Ratanawijitrasin Prescribing pattern of lipid-lowering medications before and after adoption of 2013 american college of cardiology and american heart association guidelines in Thailand: An interrupted time series analysis. Southeast Asian Journal of Tropical Medicine and Public Health. Vol.52, No.5 (2021), 717-731. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/77851
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Prescribing pattern of lipid-lowering medications before and after adoption of 2013 american college of cardiology and american heart association guidelines in Thailand: An interrupted time series analysis
Abstract
The American College of Cardiology (ACC) and the American Heart Association (AHA) in 2013 introduced new Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults (2013 ACC/AHA guideline) focusing on use of appropriate statins as first-line drugs to reduce risks of atherosclerotic cardiovascular diseases (ASCVD). The 2013 ACC/AHA guideline was adopted in Thailand in November 2013. Impact of the new guidelines on statin use in the country was assessed by examining changes in prescribing patterns of lipid-lowering agents (LLAs) pre-and post-2013 ACC/AHA guideline release using an interrupted time series (ITS) design with segmented regression analysis. Health records of patients ≥21 years of age were collected from three tertiary-care hospitals in Thailand. ITS analysis carried out on 1,597,346 LLA prescriptions of 133,212 patients revealed a statistically significant increase in prescribed high-intensity statins post-compared to pre-2013 ACC/AHA guideline release for all patients in the three study hospitals, including those with ASCVD, diabetes and primary LDL cholesterol ≥190 mg/dL (p-value <0.001 for all categories). In addition, post-2013 ACC/AHA guideline prescriptions transited from low-or moderate-to high-intensity statins. Thus, the significant rise in trend of prescribing high-intensity statins would suggest a positive impact on prescriber good practice in tertiary-care hospitals of Thailand as a result of adopting the 2013 ACC/AHA guideline.